BeyondSpring sells stake in preferred shares of SEED Therapeutics for ~$35.4M
Source: SeekingAlpha
2025-01-28 07:22:20 ET
More on BeyondSpring
Read the full article on Seeking Alpha
For further details see:
BeyondSpring sells stake in preferred shares of SEED Therapeutics for ~$35.4M
BeyondSpring Inc.
NASDAQ: BYSI
BYSI Trading
0.0% G/L:
$1.83 Last:
33,105 Volume:
$1.79 Open:
BYSI Latest News
February 09, 2026 07:15:00 am
BeyondSpring to Participate at the 12th Annual Immuno-Oncology 360° Conference
December 12, 2025 07:00:00 am
BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a Global Registration Path
December 11, 2025 07:00:00 am
BeyondSpring Announces New Analyses of DUBLIN-3 Phase 3 Study Showing Survival Benefit of Plinabulin + Docetaxel in Post Anti-PD-(L)1 for Non-squamous EGFR WT NSCLC and a Reduction in Brain Metastasis Compared to Docetaxel at NACLC 2025
November 12, 2025 07:00:00 am
BeyondSpring Reports Third?Quarter 2025 Financial Results and Provides Corporate Update
BYSI Stock Data
$61,103,465
33,177,366
3.77%
10
N/A
Biotechnology & Life Sciences
Healthcare
US
Florham Park
